Mortality outcome | Model 1 a | Model 2 b | Model 3 c | |||
---|---|---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | HR (95% CI) | P value | |
All-cause mortality | ||||||
Advanced lung cancer inflammation index | ||||||
As continuous (per 10U increment) | 0.96 [0.93, 0.99] | 0.003 | 0.96 [0.94, 0.99] | 0.008 | 0.97 [0.94, 1.00] | 0.032 |
Binaries | ||||||
 Lower ALI (≤ 50.07) | Ref |  | Ref |  | Ref |  |
 Higher ALI (> 50.07) | 0.60 [0.50, 0.73] | < 0.001 | 0.61 [0.51, 0.74] | < 0.001 | 0.64 [0.53, 0.78] | < 0.001 |
Serum vitamin D concentrations | ||||||
As continuous (per 10nmol/L increment) | 0.90 [0.86, 0.94] | < 0.001 | 0.90 [0.86, 0.95] | < 0.001 | 0.92 [0.88, 0.96] | < 0.001 |
Vitamin D categories | ||||||
 ≥ 50 nmol/L | Ref |  | Ref |  | Ref |  |
 30 to < 50 nmol/L | 1.34 [1.09, 1.65] | 0.006 | 1.57 [1.27, 1.95] | < 0.001 | 1.34 [1.08, 1.67] | 0.008 |
 < 30 nmol/L | 2.00 [1.50, 2.67] | < 0.001 | 2.58 [1.87, 3.54] | < 0.001 | 2.06 [1.50, 2.83] | < 0.001 |
Respiratory disease Mortality | ||||||
Advanced lung cancer inflammation index | ||||||
As continuous (per 10U increment) | 0.82 [0.74, 0.90] | < 0.001 | 0.82 [0.75, 0.90] | < 0.001 | 0.85 [0.77, 0.93] | < 0.001 |
Binaries | ||||||
 Lower ALI (≤ 50.07) | Ref |  | Ref |  | Ref |  |
 Higher ALI (> 50.07) | 0.31 [0.19, 0.49] | < 0.001 | 0.30 [0.18, 0.48] | < 0.001 | 0.34 [0.21, 0.55] | < 0.001 |
Serum vitamin D concentrations | ||||||
As continuous (per 10nmol/L increment) | 0.89 [0.82, 0.98] | 0.015 | 0.85 [0.77, 0.94] | 0.001 | 0.84 [0.76, 0.93] | 0.001 |
Vitamin D categories | Â | |||||
 ≥ 50 nmol/L | Ref |  | Ref |  | Ref |  |
 30 to < 50 nmol/L | 1.09 [0.62, 1.89] | 0.772 | 1.43 [0.81, 2.53] | 0.218 | 1.56 [0.86, 2.85] | 0.147 |
 < 30 nmol/L | 2.28 [1.12, 4.64] | 0.023 | 3.10 [1.45, 6.66] | 0.004 | 2.73 [1.24, 6.00] | 0.012 |